1 March 2023 à 14:27

• test

ABL AND IMUGENE PARTNER TO ADVANCE ONCOLYTIC VIRUS CANDIDATE TOWARDS LATER PHASE CLINICAL TRIALS

Read more

1 March 2023 à 14:20

• News

ABL AND RD-BIOTECH SIGN STRATEGIC PARTNERSHIP IN CELL AND GENE THERAPY GMP MANUFACTURING

Read more

1 March 2023 à 14:05

• News

ABL PARTNERS WITH KALIVIR IMMUNOTHERAPEUTICS TO ADVANCE DEVELOPMENT OF ONCOLYTIC VIRUSES

Read more

27 February 2023 à 11:00

• News

COAVE THERAPEUTICS AND ABL ENTER INTO STRATEGIC COLLABORATION

Read more

17 April 2022 à 14:23

• News

ABL AND ODIMMA THERAPEUTICS JOIN FORCES IN PERSONALIZED CANCER IMMUNOTHERAPY

Read more